GlaxoSmithKline (GSK) Probes Allegedly Fraudulent Data in Study Written by Employees
6/5/2013 10:58:30 AM
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
In the latest instance in which a global drugmaker has become embroiled in a scandal over published study results, GlaxoSmithKline is investigating whether a paper that appeared in Nature Medicine three years ago and was co-authored by more than a dozen scientists at its R&D Center in Shanghai, China, contained fabricated data.
Help employers find you! Check out all the jobs and post your resume.
comments powered by